Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study on Inhaled Levofloxacin for Treating Community-Acquired Pneumonia in Patients Without Systemic Antibiotics
DenmarkLong-Term Follow-Up Study for Patients with Myxoid/Round Cell Liposarcoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Synovial Sarcoma Treated with Letetresgene Autoleucel
FranceStudy on Patritumab Deruxtecan and Zirconium (89Zr) Patritumab Deruxtecan for Patients with Advanced EGFR Mutation Positive Lung Cancer
The NetherlandsStudy on Pembrolizumab and Olaparib for Patients with Extensive-Stage Small-Cell Lung Cancer
ItalyStudy on Budesonide for COPD Patients with Different Eosinophil Levels
GermanyStudy on the Effect of Acyclovir in ICU Patients with Pneumonia and Herpes Simplex Virus Type 1 Detected in Lung Fluid
GermanyStudy on Weaning Patients with Acute Respiratory Failure from High-Flow Nasal Oxygen Therapy Using Oxygen
FranceStudy on BI 764532 for Patients with Relapsed or Refractory Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
BelgiumStudy on Extending Dosing Intervals of Mepolizumab and Dupilumab for Patients with Severe Asthma
The NetherlandsStudy on the Effectiveness and Safety of Treprostinil and Drug Combination for Patients with Pulmonary Arterial Hypertension (Group I)
AustriaStudy on the Effectiveness of Belumosudil and Azithromycin for Adults with Chronic Lung Rejection After Lung Transplant
AustriaStudy on Long-Term Safety of Inhaled Treprostinil for Patients with Fibrotic Lung Disease
BelgiumThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
